Effects of efficient phosphate binding on bone in chronic renal failure rats

Renal Failure

Volumn 27, Issue 4, 2005, Pages 475-484

  Behets, Geert J ^a   Gritters, Mareille ^a   Dams, Geert ^a   De Broe, Marc E ^a   D'Haese, Patrick C ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Bone turnover; Lanthanum carbonate; Phosphate binding agents; Renal osteodystrophy; Sevelamer

Indexed keywords

LANTHANUM CARBONATE; PHOSPHATE; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE; BONE MINERALIZATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG MEGADOSE; MALE; MORPHOMETRICS; NEPHRECTOMY; NONHUMAN; PHOSPHATE DEFICIENCY; PHOSPHATURIA; PRIORITY JOURNAL; RAT; RENAL OSTEODYSTROPHY;

ANIMALS; BONE AND BONES; BONE DENSITY; DISEASE MODELS, ANIMAL; EPOXY COMPOUNDS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LANTHANUM; MALE; NEPHRECTOMY; OSTEOPOROSIS; PHOSPHATES; POLYAMINES; POLYETHYLENES; PROBABILITY; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 22244469128     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-65423     Document Type: Article

References (19)

1. Behets, G.J.; Verberckmoes, S.C.; D'Haese, P.C.; De Broe, M.E. Lanthanum carbonate: a new phosphate binder. Curr. Opin. Nephrol. Hypertens. 2004, 13, 403-409.
2. Joy, M.S.; Finn, W.F. Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia. Am. J. Kidney Dis. 2003, 42 (1), 96-107.
3. D'Haese, P.C.; Spasovski, G.B.; Sikole, A.; et al. A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int. 2003, 63, S73-S78.
4. Behets, G.J.; Dams, G.; Vercauteren, S.R.; Damment, S.J.; Bouillon, R.; De Broe, M.E.; D'Haese, P.C. Does the phosphate binder lanthanum carbonate affect bone in chronic renal failure rats? J. Am. Soc. Nephrol. 2004, 15, 2219-2228.
5. Plone, M.A.; Petersen, J.S.; Rosenbaum, D.P.; Burke, S.K. Sevelamer, a phosphate-binding polymer, is a non-absorbed compound. Clin. Pharmacokinet. 2002, 41 (7), 517-523.
6. Tietz, N.W.; Rinker, A.D.; Shaw, L.M. IFCC methods for the measurement of catalytic concentration of enzymes Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). J. Clin. Chem. Clin. Biochem. 1983, 21 (11), 731-748.
7. Bradford, M.M. A rapid and sensitive method for the determination of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
8. Hansen, A.C. Atomic absorption spectrophotometry for calcium and magnesium in serum and urine. At. Absorpt. Newsl. 1973, 12 (5), 125-128.
9. Bouillon, R.; De Moor, P.; Baggiolini, E.G.; Uskokovic, M.R. A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin. Chem. 1980, 26 (5), 562-567.
10. 3 in serum. Clin. Chem. 1976, 22 (3), 364-368.
11. Parfitt, A.M.; Drezner, M.K.; Glorieux, F.H.; et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J. Bone Miner. Res. 1987, 2 (6), 595-610.
12. Lotz, M.; Zisman, E.; Bartter, F.C. Evidence for a phosphorus-depletion syndrome in man. N. Engl. J. Med. 1968, 278 (8), 409-415.
13. Nagano, N.; Miyata, S.; Obana, S.; et al. Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel), a non calcemic phosphate binder. Nephron 2001, 89 (3), 321-328.
14. Cornell, C.N.; Chung-Leddon, J. Osteomalacia and hypophosphatemia. Curr. Opin. Orthop. 1995, 6 (V), 14-19.
15. Condon, J.R.; Nassim, J.R.; Rutter, A. Pathogenesis of rickets and osteomalacia in familial hypophosphatasemia. Arch. Dis. Child. 1971, 46 (247), 269-272.
16. McClure, J.; Smith, P.S. Oncogenic osteomalacia. J Clin Pathol 1987, 40 (4), 446-453.
17. Boutsen, Y.; Devogelaer, J.P.; Malghem, J.; Noel, H.; Nagant, D.D. Antacid-induced osteomalacia. Clin. Rheumatol. 1996, 15 (1), 75-80.
18. 3-responsive epithelia. J. Biol. Chem. 1999, 274 (13), 8375-8378.
19. Nagano, N.; Miyata, S.; Obana, S.; et al. Sevelamer hydrochloride (Renagel), a non-calcemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency. Nephrol. Dial. Transplant. 2001, 16 (9), 1870-1878.